{"id":"W3166073592","doi":"10.1016/s0140-6736(21)00666-8","title":"Filgotinib as induction and maintenance therapy for ulcerative colitis (SELECTION): a phase 2b/3 double-blind, randomised, placebo-controlled trial","year":2021,"lang":"en","type":"article","venue":"The Lancet","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":437,"is_retracted":false,"has_abstract":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"Gilead Sciences","keywords":"Medicine; Vedolizumab; Ulcerative colitis; Placebo; Internal medicine; Maintenance therapy; Clinical endpoint; Clinical trial; Gastroenterology; Regimen; Surgery; Chemotherapy; Disease; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001487017,0.001696364,0.004626707,0.0004451196,0.0005282062,0.001214668,0.0009386301,0.002645063,0.0110801],"category_scores_gemma":[0.001390853,0.0006540362,0.002753928,0.0004769385,0.001200597,0.001193017,0.0004183177,0.003238128,0.001459749],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007853893,"about_ca_system_score_gemma":0.0009065243,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001195873,"about_ca_topic_score_gemma":0.002450374,"domain_scores_codex":[0.9995541,0.0001716547,0.0000291711,0.00009861165,0.00003878614,0.0001075815],"domain_scores_gemma":[0.9992957,0.0002024447,0.0001537424,0.00006022579,0.00004603408,0.0002418783],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9852375,0.001345626,0.0001939998,0.0007529425,0.0006686242,0.00003094917,0.00002623287,0.0001131113,0.001412996,0.00005525247,0.0008452955,0.009317406],"study_design_scores_gemma":[0.9845671,0.0140013,0.0005972564,0.00002715472,0.0002528542,0.00002044668,0.000008723141,0.00007533373,0.00009415846,0.00005056457,0.0002987408,0.000006519134],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.961325,0.02358716,0.001025424,0.001877929,0.001467909,0.004545487,0.002274572,0.0004365464,0.003459966],"genre_scores_gemma":[0.967097,0.01072055,0.002376856,0.003535717,0.001221837,0.005463488,0.002090461,0.00007191324,0.007422216],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0110801,"threshold_uncertainty_score":0.03706658,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02777325386693909,"score_gpt":0.3148007038727766,"score_spread":0.2870274500058375,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}